Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
Cannabinoids have been reported to provide neuroprotection in acute and chronic neurodegeneration. In this study, we examined whether they are also effective against the toxicity caused by 6-hydroxydopamine, both in vivo and in vitro, which may be relevant to Parkinson's disease (PD). First, we...
Main Authors: | Isabel Lastres-Becker, Francisco Molina-Holgado, José A. Ramos, Raphael Mechoulam, Javier Fernández-Ruiz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-06-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996104002827 |
Similar Items
-
A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms
by: Débora Masini, et al.
Published: (2021-05-01) -
Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease
by: Marie-Thérèse Armentero, et al.
Published: (2006-04-01) -
Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress
by: Ahmet Özdemir, et al.
Published: (2018-08-01) -
Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson’s Disease
by: Anja Pišlar, et al.
Published: (2018-11-01) -
Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease
by: R.K. Chaturvedi, et al.
Published: (2006-05-01)